Comparison of MOPP and LOPP Treatments for Advanced Hodgkin's Disease
Author Information
Author(s): B.W. Hancock, G. Vaughan Hudson, B. Vaughan Hudson, J.L. Haybittle, M.H. Bennett, K.A. MacLennan, A.M. Jelliffe
Primary Institution: British National Lymphoma Investigation
Hypothesis
Is LOPP as effective as MOPP in treating advanced Hodgkin's disease with less toxicity?
Conclusion
LOPP is as effective as MOPP in treating advanced Hodgkin's disease and has less toxicity.
Supporting Evidence
- Complete remission rates were 63% for MOPP and 57% for LOPP.
- Overall survival rates at 5 years were 65% for MOPP and 64% for LOPP.
- Acute toxicity was less with LOPP compared to MOPP.
Takeaway
Doctors tested two treatments for a type of cancer called Hodgkin's disease. They found that one treatment worked just as well but made people feel less sick.
Methodology
Patients were randomly assigned to receive either MOPP or LOPP chemotherapy, and their outcomes were analyzed over time.
Potential Biases
Potential bias due to patient selection and treatment allocation.
Limitations
The study had a relatively small sample size and may not be generalizable to all Hodgkin's disease patients.
Participant Demographics
Patients were aged 15-49, with a mix of males and females, and included those with stage III or IV Hodgkin's disease.
Statistical Information
P-Value
0.30
Confidence Interval
0.70 to 1.48
Statistical Significance
p=0.30
Want to read the original?
Access the complete publication on the publisher's website